Don’t Miss a Single Update or New Release! Sign up Today
Our emails may go into your junk folder. Add to your mobile number to get SMS alerts.
All Weight Loss Programs
We have several options to help you with your metabolic reset, all online
WAYT-LESS
WAYT-less® is our new and improved weight-loss program!
WAYT-TAIN
WAYT-tain® is our new and improved maintain program!
DIET GUIDELINES
The WAYT-less ® Diet E-book grants you access to many practical and delicious recipes for your diet!
ULTRA BURN
Enhance your body’s natural fat-burning abilities!
B12 INJECTIONS
Increase Your Energy Levels & Improve Your Brain Performance!
Medically reviewed by
Constance Tambakis Odom, MD graduated in 1987 with her Doctorate of Medicine from the New York Medical College, and was an Anesthesiologist Resident from 1988 to 1991 at the Brookdale Medical Center PGY II (CA-I)-PGY IV (CA-III). She is Board Certified by the American Board of Anesthesiology since 1998 and American Academy of Anti-Aging Medicine since 2002. Constance Odom, MD is affiliated with the American Medical Association, American Academy of Anti-Aging Medicine, American Society of Anesthesiology, Georgia Society of Anesthesiology, Hellenic Medical Society of New York, North Carolina Society of Anesthesiology, and Society of Ambulatory Anesthesia.
In the quest for effective weight management, WAYT-less™ stands out as a comprehensive and medically prescribed treatment plan. Developed by Nu Image Medical, it combines various elements to support you on your weight loss journey. At the heart of this program lies a trio of potent medications: Low Dose Naltrexone, Acarbose, and Orlistat.
Let’s delve into how each of these medications contributes to the success of the WAYT-less™ program.
WAYT-less™ is not your ordinary weight management program; it is a supervised treatment plan that addresses the complexities of weight loss. It offers a customized approach that includes medical supervision and dietary guidance. The three medications—Low Dose Naltrexone, Acarbose, and Orlistat—play pivotal roles in this holistic solution.
Blood sugar control: Acarbose works by slowing down the digestion of carbohydrates in the small intestine, helping to regulate blood sugar levels. This prevents sharp spikes and crashes, reducing cravings for sugary and high-calorie foods.
Reduced caloric absorption: By decreasing the absorption of calories from carbohydrates, Acarbose contributes to a lower overall caloric intake, facilitating gradual and sustainable weight loss.
Satiety and portion control: Acarbose promotes a feeling of fullness, helping individuals control portion sizes and reduce overall food intake.
Improved insulin sensitivity: Enhancing insulin sensitivity makes Acarbose an excellent choice for individuals with insulin resistance, a common issue in obesity.
Medical supervision: Administered under the guidance of healthcare professionals, Acarbose ensures safe and effective use within the WAYT-less™ program.
Learn more about Acarbose and how it works in WAYT-less™
Low Dose Naltrexone (LDN)
of weight loss. It offers a customized approach that includes medical supervision
Appetite regulation: LDN has been proposed as a valuable tool for managing appetite and cravings. While traditionally used at higher doses to treat opioid and alcohol addiction, at lower doses, LDN exhibits various potential health benefits.
Metabolism support: LDN supports metabolism, helping to burn calories more efficiently.
Craving reduction: By reducing cravings, LDN helps individuals make healthier food choices, contributing to overall well-being and weight management.
Holistic health benefits: Beyond weight management, LDN offers additional health benefits, making it a unique and valuable component of the WAYT-less™ program.
Learn more about Low Dose Naltrexone and how it works in WAYT-less™
Fat blocker: Orlistat inhibits the absorption of dietary fat in the digestive tract, reducing caloric intake from fat and contributing to sustainable weight loss.
Enhanced weight Loss: When combined with a reduced-calorie diet, Orlistat accelerates weight loss compared to diet alone, helping individuals reach their goals more efficiently.
Improved Dietary Habits: Knowing that Orlistat can lead to undesirable side effects if consumed alongside high-fat meals, individuals are encouraged to make healthier food choices, essential for long-term weight management.
Medical Supervision: As part of the WAYT-less™ program, Orlistat is administered under medical supervision, ensuring safe and effective use.
Sustainable Results: Orlistat helps individuals not only lose weight but also maintain it over time, empowering them to make healthier lifestyle choices.
Learn more about Orlistat and how it works in WAYT-less™
The WAYT-less™ treatment plan
The WAYT-less™ program offers a multifaceted approach to weight management, consisting of:
Online visit: Convenient access to healthcare professionals for consultation and support.
Personalized E-Book: Customized resources and guidelines to support your weight loss journey.
No hidden fees: Transparent pricing ensures no surprises along the way.
Continuous support: Ongoing assistance from healthcare professionals.
Nutritional support: Expert dietary guidance tailored to your needs.
Discrete shipping: Medications are shipped discreetly, ensuring privacy and convenience.
WAYT-less™, with its trio of medications—Acarbose, Low Dose Naltrexone, and Orlistat—represents a comprehensive and medically supervised approach to weight management. Each medication brings unique benefits, from regulating blood sugar and reducing caloric absorption to blocking fat and reducing cravings. Together, they form a powerful combination that supports you on your journey to a healthier and happier life.
This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your physician about the risks and benefits of any treatment. Nu Image Medical may not offer the medications or services mentioned in this article.